-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Titan Pharmaceuticals Inc quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2011 to Q1 2024.
- Titan Pharmaceuticals Inc Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $2K, a 95.3% decline year-over-year.
- Titan Pharmaceuticals Inc annual Depreciation, Depletion and Amortization for 2023 was $112K, a 42.9% decline from 2022.
- Titan Pharmaceuticals Inc annual Depreciation, Depletion and Amortization for 2022 was $196K, a 11.3% decline from 2021.
- Titan Pharmaceuticals Inc annual Depreciation, Depletion and Amortization for 2021 was $221K, a 24.3% decline from 2020.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)